| Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany. | |
| | |
MedLine Citation:
|
PMID: 22282711 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Cryopreserved ovarian tissue can be retransplanted to restore fertility after radiation or chemotherapy. To date, 15 live births after retransplantation have been reported worldwide. We report the first pregnancy and the first live birth after retransplantation in Germany. CASE REPORT: A 25-year-old female patient received initial chemotherapy and radiation of the mediastinum for Hodgkin's lymphoma in 2003 and suffered a relapse two years later. Ovarian tissue was laparoscopically removed and cryopreserved, and she was then treated with high-dose chemotherapy and stem cell transplantation. She remained in remission for 5 years and she could not conceive during this time. The cryopreserved ovarian tissue was thawed and laparoscopically retransplanted into a peritoneal pouch in the ovarian fossa of the right pelvic wall. Three months later, her menopausal symptoms resolved, and she had her first spontaneous menstruation. Six months after retransplantation, after two normal menstrual cycles, low-dose follicle stimulating hormone (FSH) treatment induced the appearance of a dominant follicle in the tissue graft. Ovulation was then induced with human chorionic gonadotropin (HCG), whereupon the patient conceived naturally. After an uncomplicated pregnancy, she bore a healthy child by Caesarean section on 10 October 2011. Histological examination of biopsy specimens revealed that the ovarian tissue of the graft contained follicles in various stages of development, while the original ovaries contained only structures without any reproductive potential. CONCLUSION: This was the first live birth after retransplantation of cryopreserved ovarian tissue in Germany and also the first case with histological confirmation that the oocyte from which the patient conceived could only have come from the retransplanted tissue. In general, young women who will be undergoing chemotherapy and/or radiotherapy for cancer must be informed and counseled about the available options for fertility preservation. |
| | |
Authors:
|
Andreas Müller; Katja Keller; Jennifer Wacker; Ralf Dittrich; Gudrun Keck; Markus Montag; Hans Van der Ven; David Wachter; Matthias W Beckmann; Wolfgang Distler |
Publication Detail:
|
Type: Journal Article Date: 2012-01-09 |
Journal Detail:
|
Title: Deutsches Ärzteblatt international Volume: 109 ISSN: 1866-0452 ISO Abbreviation: Dtsch Arztebl Int Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-01-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101475967 Medline TA: Dtsch Arztebl Int Country: Germany |
Other Details:
|
Languages: eng Pagination: 8-13 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Atrial fibrillation: established and innovative methods of evaluation and treatment.
Next Document: The differential diagnosis and treatment of normal-pressure hydrocephalus.